Immunonanoparticles for targeting and delivery of protein drugs into tumour cells


    loading  Checking for direct PDF access through Ovid

Abstract

Cystatin, a protein inhibitor of cysteine proteases with potential antitumoural activity, was incorporated in poly(lactide-co-glycolide) nanoparticles, which were further surface-modified with monoclonal antibody, recognizing specific antigen overexpressed on invasive breast tumour cells (MCF-10A neoT). Results showed that immunonanoparticles were able to recognize and target the antigen on MCF-10A neoT cells in a co-culture with other cells. Following endocytosis, cystatin delivered by immunonanoparticles (immuno-NPs), effectively inhibited intracellular cathepsin B only in the target cells.

    loading  Loading Related Articles